Skip to main content
PMC home page
Journal of Sports Science & Medicine logoLink to Journal of Sports Science & Medicine
. 2010 Jun 1;9(2):183–189.

Effects of Caffeine on Exercise Performance in Sedentary Females

Karen E Wallman 1,✉, Jin W Goh 1, Kym J Guelfi 1
PMCID: PMC3761740  PMID: 24149684

Abstract

The purpose of the study was to examine the effect of caffeine ingestion on total work, average power, oxygen consumption (VO2), respiratory exchange ratio (RER), ratings of perceived exertion (RPE), heart rate (HR) and energy expenditure (kJ) during stationary cycling at a standardised power output, as well as during a set time period where participants were required to cycle as fast as they could. Ten healthy, sedentary, female, non- regular caffeine users completed 15 min of stationary cycling at a standardised power output equating to 65% HRmax (Phase A), followed by 10 min of stationary cycling where they were required to cycled as fast as they could (Phase B) after ingesting 6.0 mg·kg-1 of caffeine or placebo 60 min prior to exercise. VO2 and energy expenditure were significantly higher at the end of Phase A (p = 0.008 and p = 0.011, respectively). All other variables examined in Phase A were similar between trials. In Phase B, there were no significant differences found for any variable assessed. While caffeine ingestion resulted in significant increases in VO2 and energy expenditure during steady-state exercise, it did not improve cycling performance during a 10 min trial where participants were required to cycle as fast as they could.

Key points.

  • A 6.0 mg·kg-1 dose of caffeine did not improve work done (J·kg-1) or mean power (W) during 10 min of self-paced stationery cycling in sedentary female participants.

  • A 6.0 mg·kg-1 dose of caffeine significantly increased VO2 and energy expenditure (kJ) during 15 min of steady-state stationery cycling in sedentary female participants.

  • A 6.0 mg·kg-1 dose of caffeine did not significantly affect RPE, RER or HR during 15 min of steady-state cycling or 10 min of cycling performed as fast as the participant could achieve, when compared to placebo, in sedentary female participants.

Key words: Sub-maximal exercise, rating of perceived exertion, energy expenditure, weight maintenance

Introduction

The common belief that caffeine improves both mental and physical performance, combined with the removal of caffeine from the banned substances list on the 1st of January 2004 by the World Anti-Doping Agency (WADA, 2008), has led to its widespread use amongst athletes competing in many sports. To date, many research trials have demonstrated caffeine to be an ergogenic aid for exercise of varying intensities, durations and modalities in an athletic population (Bell and McLellan, 2002; Bridge and Jones, 2006; Bruce et al., 2000; Doherty and Smith, 2005; Graham, 2001; Plaskett and Cafarelli, 2001; Schneiker et al., 2006; Stuart et al., 2005). Benefits associated with caffeine ingestion in this population include delayed feelings of fatigue (Anselme et al., 1992; Jackman et al., 1996), reduced sensations of pain and exertion (Bell and McLellan, 2002), increased time to exhaustion (Graham and Spriet, 1991), increased fatty acid oxidation (Chad and Quigley, 1989), increased mean power output (Anderson et al., 2000), decreased times to complete a set amount of work (Bridege and Jones, 2006), stimulation of motor activity (Fisone et al., 2004), as well as an increase in alertness, feelings of subjective energy and ability to concentrate (Keisler and Armsey, 2006; Lorist et al., 1994). While the precise reasons underlying the ergogenic effects of caffeine remain equivocal, it is generally accepted that the most likely mechanism is adenosine receptor antagonism (Graham, 2001). When the body is under increased metabolic demand, circulating adenosine is increased in order to decrease activity. By attaching to adenosine receptors, caffeine is able to counteract many of the inhibitory effects of endogenous adenosine on neuro-excitability (Kalmar and Cafarelli, 2004), neurotransmitter release (Fredholm et al., 1999) and arousal (Porkka-Heiskanen, 1999).

The effects of caffeine on physical performance (walking, cycling and aerobic-dance bench stepping) have also been assessed to a lesser degree in non-athletic but recreationally active populations (Ahrens et al., 2007a; 2007b; Engles et al., 1999). These studies reported that caffeine significantly increased the rate of energy expenditure (REE), oxygen uptake (VO2: Ahrens et al., 2007a; Engels et al., 1999), and the percentage of maximal VO2 uptake reserve (Ahrens et al., 2007a), but did not alter sense of effort (Ahrens et al., 2007a; 2007b), heart rate (HR; Ahrens et al., 2007a; 2007b) or respiratory exchange ratio (RER: Ahrens et al., 2007a; 2007b; Engels et al., 1999). Of relevance, various limitations were associated with these studies that may have affected results. For example, there was no fasting period prior to the exercise protocols (Ahrens et al., 2007a; 2007b), cohorts consisted of mixed genders (Engels et al., 1999) and menstrual cycle phases were not controlled for (Ahrens et al., 2007a; 2007b; Engels et al., 1999), with the luteal phase being associated with greater pain sensitivity (Fillingrim and Ness, 2000). Furthermore, none of these studies assessed the effects of caffeine on the ability to perform more work.

Of importance, the ability to perform more work after caffeine ingestion, as demonstrated in athletic populations, can result in greater caloric expenditure and the possibility of improved fitness if the exercise is maintained over an extended period of time. These benefits, combined with the proposed increase in fatty acid oxidation associated with caffeine ingestion (Chad and Quigley, 1989), are pertinent to populations characterised by sedentary lifestyles that in turn can result in weight gain and consequent health issues. Of relevance, there has been only one published study to date known to the authors that has assessed the effects of caffeine on exercise in a sedentary population (Engels and Haymes, 1992). These researchers reported significantly higher minute ventilation, as well as an increase in pre and post exercise free fatty acids associated with a 60 min walking protocol in sedentary males following caffeine ingestion. However, the ability to perform more work during this time period was not assessed. Consequently, further well-controlled studies are needed to assess the effects of caffeine in a sedentary population, with particular focus on caffeine’s ability to increase fatty acid oxidation, lower effort sensation and improve work performance.

Therefore, the first aim of this study was to examine the effect of caffeine ingestion on VO2, RER, RPE and HR during 15 min of stationary cycling at a standardised power output in a sedentary, female population. Secondly, the effect of caffeine ingestion on 10 min of self-paced stationary cycling, where participants were required to cycle as fast as they could during this time period, was also assessed. Based on the reported ergogenic benefits of caffeine on exercise, it was hypothesised that compared to a placebo, caffeine ingestion would result in lower RPE values and greater fatty acid oxidation as indicated by a decrease in RER values during stationary cycling at a set power output. It was also hypothesised that participants would cycle at a significantly higher intensity overall and complete more total work during the 10 min stationary cycling trial after caffeine ingestion.

Methods

Ten healthy, sedentary, females who were non-regular caffeine users (<100 mg per day) volunteered for this study (mean ± SD: age 22 ± 2 yr; height 1.65 ± 0.11 m; body-mass 61.9 ± 14.8 kg; BMI 22.7 ± 3.0). The participants were initially screened using the PAR-Q, as well as a detailed questionnaire that assessed caffeine consumption habits. Individuals who participated in more than 20 min of exercise performed on three or more days per week were considered ineligible for the study. Prior to testing, participants gave informed consent and the study was approved by the human ethics committee of the University of Western Australia (UWA).

Each participant reported to the Exercise Physiology Laboratory at UWA on three separate occasions: once for a familiarisation session, followed by two experimental sessions involving stationary cycling following the administration of either caffeine or placebo in a double-blind, randomised, crossover design. The participants were instructed to refrain from consuming caffeine for 48 h prior to each testing session, as well as to avoid exercise for 24 h prior. The same instructions applied to all visits. A list of food and beverages containing caffeine was provided to each participant in order to inform them of what products they should avoid. Participants were also asked to keep a diary documenting their diet 24 h prior to the first testing session and to replicate this diet before each subsequent visit.

The familiarisation session required participants to complete a graded exercise protocol on a bicycle ergometer (Exertech EX-10 front access cycle ergometer, Repco Cycle Company, Huntingdale, Victoria) in order to determine the power output required to elicit a target HR equating to 65% of individual age-predicted maximum HR (220 - age). Percentage HRmax was chosen over %VO2max in an effort to make the study less onerous for the sedentary participants. This procedure involved a starting workload of 25 Watts (W) that increased by 25 W increments every three minutes, until the target HR was reached. Once the target HR was attained, the participants continued to cycle at the power output that equated to this HR value for a duration of 15 min. During this time, the participants breathed through a mouthpiece attached to a Hans-Rudolf valve connected to a computerised gas analysis system comprising of a Morgan ventilation monitor (Morgan, Reinham, Kent, UK), an oxygen analyser (Ametek SOV S-3A11, Applied Electrochemistry, Ametek, Pittsburgh, PA) and a carbon dioxide analyser (Ametek COV CD-3A, Applied Electrochemistry, Ametek, Pittsburgh, PA). Both the Morgan ventilometer and gas analysers were calibrated before testing using a 1 L syringe and a certified gravimetric standard gas mixture (BOC Gases, Chatswood, Australia) of known composition, respectively. After this initial 15 min of cycling, the participants were allowed 5 min of passive rest before commencing another 10 min bout of cycling where they were required to cycle as fast as they could within this time frame. During this second phase of the exercise, participants were constantly motivated by the researcher and regularly (every minute) advised of the time remaining. Of importance, the time periods of 15 and 10 min were selected as a result of pilot testing that indicated that sedentary participants had difficulty in coping with longer exercise periods that were comprised of the two phases of cycling used in this protocol. The 10 min time period selected for the second phase of the protocol is similar to that used in other studies that assessed caffeine ingestion in recreationally active adults and used set time trials of only 8 mins (Ahrens et al., 2007a; 2007b).

The experimental trials were then conducted between days 3 and 11 of each participant’s menstrual cycle (follicular phase) with approximately 4 weeks between trials. Prior to each testing session, participants were given a capsule containing either caffeine (6.0 mg·kg-1 body mass; No- Doz®, Key Pharmaceuticals Pty Ltd, Rhodes, NSW, Australia) or placebo (6.0 mg·kg-1 body mass; Sucaryl sweetener) and were instructed to ingest the given capsule at 6.30 am on the day of testing whilst at home. The dose of 6.0 mg·kg-1 was selected based on previous studies that used this dose and reported performance benefits (Carr et al., 2008; Schneiker et al., 2006; Stuart et al., 2005). The participants were then required to arrive at the Exercise Physiology Laboratory at UWA by 7.15 am in a fasted state, having not ingested food or beverages besides water for the previous 12 h period. At 7.30 am, baseline HR was recorded using a Polar HR monitor (Polar Electro Oy, Kempele, Finland) and exercise testing began. The exercise testing was divided into two phases. The first phase (Phase A) involved 15 min of stationary cycling performed at a constant power output that equated to 65% of the individual’s age predicted HRmax, as determined during the familiarisation session. During this period, the participants breathed through a mouthpiece connected to the previously described computerised gas analysis system for the analysis of VO2, RER and energy expenditure (kJ and kJ.min-1). In addition, HR and RPE (6 - 20 scale: Borg, 1982) were recorded at 5 min intervals throughout the exercise protocol. Upon the completion of Phase A, participants were required to rest passively for 5 min and then to cycle for a further 10 min as fast as they could (Phase B, see details described earleir). During this phase, the average power output and total work completed were recorded using the software Cyclemax (School of Sports Science, Exercise and Health, UWA). Of importance, the participants were not provided with any visual or verbal feedback regarding their work intensity. Heart rate and RPE, were recorded every 5 min while VO2, RER and energy expenditure were calculated at 30 s intervals by software associated with the metabolic cart (META2000, UWA, Perth Australia). A slow, active warm down was then conducted prior to participants leaving the laboratory.

Data analysis

Average results for total work done, overall mean power output and total energy expenditure recorded between trials during both Phase A and Phase B of the experimental trials were analysed separately using one-way ANOVAs. Two-way repeated measures ANOVA’s were also used in order to assess the results for individual 5 min blocks of the above measures, as well as HR, RPE, VO2 and RER during both phases of the protocol (time and trial). Statistical significance was set at p ≤ 0.05 and Bonferroni post hoc comparisons were made where appropriate. All data was was analysed using SPSS (Version 13.0 for Windows; SPSS Inc, Chicago, IL).

Results

Phase A

The effect of caffeine on overall mean power output and the total amount of work performed during Phase A is summarised in Table 1. There were no significant differences between these two variables for the two trials (p = 0.26 for total work done and p = 0.14 for overall mean power output; Table 1). Further, when the total 15 min period of Phase A was divided into 5 min blocks, there was no significant interaction effect of time and trial for either of these variables (Table 1). Caffeine ingestion did however have a significant effect on total energy expenditure during Phase A (p = 0.01; Table 1). Further, when Phase A was divided into 5 min blocks, the interaction of time and trial on energy expenditure approached significance (p = 0.07; Table 1). Post-hoc analysis revealed that there was a significant increase in energy expenditure at the 15 min mark of the exercise trial after caffeine ingestion compared to the placebo trial (p = 0.007).

Table 1.

Effect of caffeine or placebo on the total amount of work done, mean power and energy expenditure during 15 min of steady state cycling (Phase A). Values are means (±SD, n = 10).

Time Placebo Caffeine Mean change (%)
± 90% confidence limits		 P
Work done
(J·kg-1) 		5 min 281 (86) 271 (66) -.11 (.19)
10 min 279 (74) 273 (64) -.07 (.11)
15 min 277 (73) 280 (81) .03 (.09)
Total 837 (232) 825 (210) .05 (.08) .39
Mean power (Watts) 5 min 55 (15) 54 (15) -.06 (.20)
10 min 56 (15) 56 (14) -.03 (.09)
15 min 56 (16) 56 (15) -.01 (.10)
Overall 57 (16) 55 (14) -.12 (.14) .80
Energy
(kJ·min-1) 		5 min 20 (5) 21 (4) .20 (.20)
10 min 21 (5) 21 (4) .08 (.19)
15 min 20 (5) 22 (5) .48 (.25)
Energy (kJ) Total 304 (296) 322 (315) * .25 (.14) .07
Open in a new tab

P indicates interaction effect of time and trial.

* indicates a significant difference (p = 0.01) in total energy (kJ) values between trials based on results from a one-way ANOVA analysis.

While there were no significant interaction effects of time and trial for HR, RPE or RER, changes in VO2 approached significance (p = 0.08; Table 2). Post-hoc analysis revealed that VO2 was significantly higher at the 15 min mark of the caffeine trial compared to the placebo trial (p = 0. 008; Table 2).

Table 2.

Effect of caffeine or placebo on heart rate (HR), rating of perceived exertion (RPE), oxygen uptake (VO2) and respiratory exchange ratio (RER) during 15 min of steady state cycling (Phase A). Values are means (±SD, n=10).

Time Placebo Caffeine Mean change (%) ± 90%
confidence limits		 P
HR 5 min 130 (12) 129 (10) -.07 (.57)
10 min 134 (10) 136 (13) -.37 (.68)
15 min 138 (12) 140 (12 .23 (.61) .81
RPE 5 min 11 (2) 10 (2) -.04 (.56)
10 min 11 (2) 11 (2) -
15 min 11 (2) 11 (2) - .74
VO2 (mL·kg-1·min-1) 5 min 16.05 (3.92) 16.93 (4.03) .22 (.24)
10 min 16.79 (3.91) 17.27 (3.33) .12 (.19)
15 min 15.85 (3.64) 17.78 (3.93) .53 (.28) .08
RER 5 min .95 (.08) .94 (.08) -.21 (.52)
10 min .89 (.05) .91 (.07) .43 (1.18)
15 min .90 (.04) .88 (.08) -.35 (.73) .31
Open in a new tab

P indicates interaction effect of time and trial.

Phase B

No significant differences were found for the total amount of work performed, overall mean power or total energy expenditure during the 10 min period of self-paced cycling between the two conditions (p = 0.27, p = 0.32 and p = 0.16, respectively), or when individual 5 min blocks were analysed (Table 3). Further, there were no significant interaction effects (time and trial) for HR, RPE, VO2, or RER (Table 4) during the 10 min time trial of self-paced cycling.

Table 3.

Effect of caffeine or placebo on the total amount of work, mean power and energy expenditure during 10 min of self-selected intensity cycling (Phase B). Values are means (±SD, n=10).

Time Placebo Caffeine Mean change (%) ±
90% confidence limits		 P
Workdone
(J·kg-1) 		5 min 423 (85) 470 (95) .55 (.52)
10 min 410 (74) 406 (49) -.05 (.67)
Total 833 (142) 876 (109) -.06 (.38) .19
Mean power (Watts) 5 min 86 (29) 92 (29) .19 (.36)
10 min 84 (23) 90 (28) .28 (.45)
Overall 85 (25) 90 (26) -.14 (.60) .92
Energy 5 min 28 (7) 31 (8) .34 (.40)
(kJ·min-1) 10 min 30 (8) 32 (8) .33 (.47)
Energy (kJ) Total 289 (280) 314 (302) .17 (.50) .93
Open in a new tab

P indicates interaction effect of time and trial.

Table 4.

Heart rate (HR), rating of perceived exertion (RPE), oxygen uptake (VO2) and respiratory exchange ratio (RER) during 10 min of self-selected intensity cycling (Phase B). Values are means (±SD, n=10).

Time Placebo Caffeine Mean change (%)
± 90% confidence limits		 P
HR 5 min 159 (17) 169 (14) .59 (.50)
10 min 167 (21) 178 (10) .53 (.49) .69
RPE 5 min 13 (2) 13 (2) -.06 (.38)
10 min 15 (2) 14 (2) -.14 (.60) .79
VO2(mL.kg-1.min-1) 5 min 21.74 (3.41) 23.59 (4.28) .54 (.69)
10 min 22.97 (4.43) 25.22 (4.31) .51 (.69) .75
RER 5 min .99 (.08) 1.01 (.09) .23 (.59)
10 min .94 (.05) .95 (.06) .08 (.63) .43
Open in a new tab

P indicates interaction effect of time and trial.

Six of the ten participants correctly identified their exposure to caffeine, due to feelings of restlessness, hyperactivity and shaky hands and legs. The remainder believed that they had not received the caffeine treatment, based on the fact that they did not feel any effects associated with caffeine ingestion.

Discussion

While the ergogenic benefits of caffeine have been well established in athletes, this is not the case in a sedentary population. Of importance, benefits associated with caffeine ingestion, i.e. the ability to perform more work, as well as a reduced sense of effort associated with exercise could be used to promote initial exercise performance in sedentary individuals who are prone to weight gain and associated health issues. Therefore, this study assessed the effect of caffeine on physiological variables in 10 sedentary females during a 15 min steady state aerobic exercise, as well as during a 10 min exercise protocol where participants were required to cycle as fast as they could. Overall, results from this study showed that caffeine resulted in significant increases in energy expenditure and VO2 uptake during the steady state protocol (phase A) only.

These results were surprising considering the convincing evidence for significantly greater work being performed in set times after caffeine ingestion in an athletic population (Bridege and Jones; 2006; Collomp et al., 1992; Ivy et al., 1979; Schneiker et al., 2006). Furthermore, a meta analysis by Doherty and Smith, 2005 reported that when compared to placebo, caffeine ingestion resulted in a 6% reduction in RPE during constant rate exercise. Lack of significant differences in exercise performance and other physiological variables may be due to the use of exercise durations (15 min for phase A and 10 min for phase B) which were considerably shorter than those undertaken in athletic studies that reported significant performance benefits (i.e. ≥ 30 min; Costill et al., 1978; Dodd et al., 1993; Graham and Spriet, 1991; Ivy et al., 1979). This conjecture is further supported by results from Ahrens et al., 2007a and Ahrens et al., 2007b that showed no significant change in RPE, HR and RER following caffeine ingestion during exercise protocols that lasted for only 8 min in recreationally fit women. Possibly a longer exercise duration is needed for the mechanisms that underlie the ergogenic effects of caffeine to result in significant differences. Further, use of %VO2max rather than %HRmax as a guide for exercise intensity during phase A of the exercise protocol may have resulted in different physiological outcomes due to variability associated with HR values. Nonetheless, every effort was made to perform the exercise trials under similar conditions in order reduce HR variability (see methods section).

Training status may also play a role in eliciting exercise performance benefits associated with caffeine ingestion. To date, the majority of studies that reported significant improvement in exercise performance following caffeine ingestion involved well-trained athletes, whereas the effects of caffeine may be different in a nonathletic population. This premise is supported by studies that assessed the effects of caffeine ingestion compared to placebo in sedentary males (Engels and Haymes, 1992), as well as in recreationally active individuals (Engels et al., 1999, Ahrens et al., 2007a; 2007b) and reported no significant differences in RPE (Ahrens et al., 2007a; 2007b; Engels et al., 1999), HR (Ahrens et al., 2007a; 2007b; Engels et al., 1999) or RER (Ahrens et al., 2007a; 2007b; Engels et al., 1999) during exercise. Of relevance, only steady-state exercise was performed in these studies and total work output was not assessed. It can be speculated that adaptive physiological changes that occur in trained athletes may result in greater responsiveness or sensitivity to caffeine uptake and its consequent effects. This may further imply that a higher dose of caffeine may be needed in a sedentary population in order to induce physiological benefit. To date, apart from the current study, only a 5 mg·kg-1 dose of caffeine has been trialed in a sedentary population (Engels and Haymes, 1992), while 3 - 6 mg·kg-1 doses have been used in studies involving recreationally active individuals (Ahrens et al., 2007a; 2007b; Engels et al., 1999). Further, the significantly lower RER values associated with caffeine ingestion reported in many endurance studies involving athletes (Bell and McLellan, 2002; Chad and Quigley, 1989; Costill et al., 1978; Graham and Spriet, 1991) may in part be due to the greater reliance fitter individuals have on fatty acids as a fuel source (McArdle et al., 2001) combined with caffeine’s purported ability to mobilise free fatty acids (Engels and Haymes, 1992). Conversely, deconditioning, which in turn results in greater reliance on CHO as an energy source, may partly explain the insignificant difference found between RER values in sedentary participants in the current study. Again, adaptive processes that accompany regular exercise training may be required to induce significantly greater fatty acid use as a fuel (reflected by lower RER values) during endurance exercise. Further studies are needed to assess the effect of caffeine ingestion in untrained versus trained participants.

In addition, it is possible that caffeine ingestion may only have an ergogenic effect in a sedentary population when exercise is performed at higher exercise intensities. For instance, Engels et al., 1999 reported no significant change to VO2 and RER in sedentary males after caffeine ingestion whilst walking at intensities equivalent to 30% and 50% VO2max. Of relevance, the higher intensity exercise employed by Engels and Haymes, 1992 is similar to the intensity used during steady-state cycling in the current study that equated to 65% individual HRmax (McArdle et al., 2001), which also resulted in similar results between caffeine and placebo trials. Conversely, a review by Graham, 2001 noted that the majority of studies that reported improvement in exercise performance in an athletic population following caffeine ingestion used exercise intensities between 75-85% VO2max. Another explanation for the results of this study may pertain to participants not being accustomed to regular exercise and consequently being reluctant to extend themselves during phase B of the protocol due to fear of injury or lack of confidence in their capabilities. The inclusion of extra exercise sessions may boost exercise confidence, which in turn may result in more work being performed during a set time, self-paced exercise routine.

Significantly higher VO2 uptake associated with steady state exercise (phase A) after caffeine ingestion was also reflected by significantly higher energy expenditure. Previous studies assessing the effect of caffeine ingestion in a non-athletic population have reported mixed findings on VO2 uptake during exercise. Engels et al., 1999 reported a significant increase in VO2 and energy expenditure, without change in RER, after caffeine ingestion in recreationally active adults during a 60 min cycle exercise and suggested that these results were due to a number of mechanisms involving caffeine’s stimulatory effects. Another study by Ahrens et al., 2007a reported a significant 4% increase in VO2 with just 8 min of treadmill walking performed at a moderate intensity, while Engels and Haymes, 1992 reported no significant differences in VO2 values following either caffeine or placebo ingestion during 60 min of walking at either 30% and 50% VO2max. The increase in VO2 reported by Ahrens et al., 2007a was proposed to be due to an increase in stroke volume considering that HR values were not significantly different between trials (based on the Fick equation). This conjecture was also proposed by Hartley et al., 2004, who reported an increase in VO2 as a consequence of a higher stroke volume (but not HR) in women at rest and during mental stress 45 min after a 3.3 mg·kg-1 ingestion of caffeine. As HR values were similar between trials in the current study, it is possible that an increase in stroke volume may have been responsible for the higher VO2 and hence energy expenditure reported after caffeine ingestion during the steady-state cycling phase of the exercise. Other possible mechanisms responsible for these increases may relate to the stimulatory affects associated with caffeine ingestion (i.e. increased catecholamine release; Graham, 2001).

Conclusion

This study demonstrated that a moderate dose of caffeine did not improve cycling performance undertaken over a 10 min period in sedentary females, however caffeine ingestion significantly increased VO2 and energy expenditure during steady state exercise. While this increase in energy expenditure represented only a 22 kJ difference between trials, this increase could be magnified if exercise duration and frequency were increased. It is possible that initial small improvements seen in the ability to exercise via caffeine ingestion may motivate sedentary individuals to make exercise a regular habit. This in turn could result in positive implications for weight management, fitness and health. Of importance, the addictive nature of caffeine, combined with possible associated health issues, such as sleep disorders (Landolt et al., 1995), caffeine induced anxiety (Fredholm et al., 1999), and raised mean arterial blood pressure (James et al., 1991), should be clearly described to individuals, with caffeine only used as a motivating tool during the initial stages of an exercise program. Further studies investigating the effect of caffeine in a sedentary population should use extra exercise sessions, longer exercise durations and higher intensities, as well as higher doses of caffeine.

Acknowledgments

All financial costs of this project were covered by the School of Sports Science, Exercise and Health at the University of Western Australia.

Biographies

Karen E. Wallman

Employment

Associate professor at the University of Western Australia (UWA).

Degree

PhD.

Research interests

Exercise and cancer, chronic fatigue syndrome and obesity.

E-mail: kwallman@cyllene.uwa.edu.au

Jin W. Goh

Degree

Bachelor of Science, Honours.

Research interests

Caffeine in a sedentary population

Kym J. Guelfi

Employment

Assistant professor at the University of Western Australia (UWA).

Degree

PhD.

Research interests

Diabetes, pregnancy and exercise, and the relationship between exercise and food intake.

References

  1. Ahrens J.N., Crixell S.H., Lloyd L.K., Walker J.L. (2007a) The physiological effects of caffeine in women during treadmill walking. Journal of Strength and Conditioning Research 21(1), 164-168 [DOI] [PubMed] [Google Scholar]
  2. Ahrens J.N., Lloyd L.K., Crixell S.H., Walker J.L. (2007b) The effects of caffeine in women during aerobic-dance bench stepping. International Journal of Sport Nutrition and Exercise Metabolism 17, 27-34 [DOI] [PubMed] [Google Scholar]
  3. Anderson M.E., Bruce C.R., Fraser S.F., Stepto N.K., Klein R., Hopkins W.G., Hawley J.A. (2000) Improved 2000-meter rowing performance in competitive oarswomen after caffeine ingestion. International Journal of Sport Nutrition and Exercise Metabolism 10 (4), 464-475 [DOI] [PubMed] [Google Scholar]
  4. Anselme F., Collomp K., Mercier B., Ahmaïdi S., Prefaut C. (1992) Caffeine increases maximal anaerobic power and blood lactate concentration. European Journal of Applied Physiology and Occupational Physiology 65(2), 188-191 [DOI] [PubMed] [Google Scholar]
  5. Bell D.G., McLellan T.M. (2002) Exercise endurance 1, 3, and 6 h after caffeine ingestion in caffeine users and nonusers. Journal of Applied Physiology 93, 1227-1234 [DOI] [PubMed] [Google Scholar]
  6. Bridge C.A., Jones M.A. (2006) The effect of caffeine ingestion on 8 km run performance in a field setting. Journal of Sports Sciences 24(4), 433-439 [DOI] [PubMed] [Google Scholar]
  7. Bruce C.R., Anderson M.E., Fraser S.F., Stepto N.K., Klein R., Hopkins W.G., Hawley J.A. (2000) Enhancement of 2000-m rowing performance after caffeine ingestion. Medicine and Science in Sports and Exercise 32(11), 1958-1963 [DOI] [PubMed] [Google Scholar]
  8. Carr A., Dawson B., Schneiker K. T., Goodman C., Lay B. (2008) Effect of caffeine supplementation on repeated sprint running performance. Journal of Sports Medicine and Physical Fitness 448(4), 472-478 [PubMed] [Google Scholar]
  9. Chad K., Quigley B. (1989) The effects of substrate utilization, manipulated by caffeine on post-exercise oxygen consumption in untrained female subjects. European Journal of Applied Physiology 59, 48-54 [DOI] [PubMed] [Google Scholar]
  10. Collomp K., Ahmaidi S., Chatard J. C., Audran M., Prefaut C. (1992) Benefits of caffeine ingestion on sprint performance in trained and untrained swimmers. European Journal of Applied Physiology 64, 377-380 [DOI] [PubMed] [Google Scholar]
  11. Costill D.L., Dalsky G.P., Fink W.J. (1978) Effects of caffeine ingestion on metabolism and exercise performance. Medicine and Science in Sports 10(3), 155-158 [PubMed] [Google Scholar]
  12. Dodd S., Herb R., Powers S.K. (1993) Caffeine and exercise performance-an update. Sports Medicine 115(1), 14-23 [DOI] [PubMed] [Google Scholar]
  13. Doherty M., Smith P.M. (2005) Effects of caffeine ingestion on rating of perceived exertion during and after exercise: A meta analysis. Scandinavian Journal of Medicine and Science in Sports 15, 69-78 [DOI] [PubMed] [Google Scholar]
  14. Engels H.J., Haymes E.M. (1992) Effects of caffeine ingestion on metabolic responses to prolonged walking in sedentary males. International Journal of Sport Nutrition 2, 386-396 [DOI] [PubMed] [Google Scholar]
  15. Engels H.J., Wirth J.C., Celik S., Dorsey J.L. (1999) Influence of caffeine on metabolic and cardiovascular functions during sustained light intensity cycling and at rest. International Journal of Sport Nutrition 9, 361-370 [DOI] [PubMed] [Google Scholar]
  16. Fillingim R.B., Ness T.J. (2000) Sex related hormonal influences on pain and analgesic responses. Neuroscience & Behavioral Reviews 24(4), 485-501 [DOI] [PubMed] [Google Scholar]
  17. Fisone G., Borgkvist A., Usiello A. (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cellular and Molecular Life Sciences 61(7-8). 857-874 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fredholm B., Battig K., Holmen J., Nehlig A., Zvartau E.E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews 551(1), 83-133 [PubMed] [Google Scholar]
  19. Graham T.E. (2001) Caffeine and exercise: metabolic, endurance and performance. Sports Medicine 31(11), 785-807 [DOI] [PubMed] [Google Scholar]
  20. Graham T.E., Spriet L.L. (1991) Performance and metabolic responses to a high caffeine dose during prolonged exercise. Journal of Applied Physiology 71(6), 2292-2298 [DOI] [PubMed] [Google Scholar]
  21. Hartley T.R., Lovallo W.R., Whitsett T.L. (2004) Cardiovascular effects of caffeine in men and women. The American Journal of Cardiology 93(8), 1022-1026 [DOI] [PubMed] [Google Scholar]
  22. Ivy J.L., Costill D.L., Fink W.J., Lower R.W. (1979) Influence of caffeine and carbohydrate feedings on endurance performance. Medicine and Science in Sports 11(1), 6-11 [PubMed] [Google Scholar]
  23. Jackman M.P., Wendling D., Friars D., Graham T.E. (1996) Metabolic, catecholamine, and endurance responses to caffeine during intense exercise. Journal of Applied Physiology 881(4), 1658-1663 [DOI] [PubMed] [Google Scholar]
  24. James J. (1991) Caffeine and Health. Academic Press, London, 1-432 [Google Scholar]
  25. Kalmar J.M., Cafarelli E. (2004) Caffeine: A valuable tool to study central fatigue in humans? Exercise and Sport ScienceReviews 332(4), 143-147 [DOI] [PubMed] [Google Scholar]
  26. Keisler B.D., Armsey T.D. (2006) Caffeine as an ergogenic aid. Current Sports Medicine Reports 55, 215-219 [DOI] [PubMed] [Google Scholar]
  27. Landolt H., Dijk D., Gaus S., Borbely A. (1995) Caffeine reduces low frequency delta activity in the human sleep EEG. Neuropsychopharmacology 112, 229-238 [DOI] [PubMed] [Google Scholar]
  28. Lorist M.M., Snel J., Kok A. (1994) Influence of caffeine on information processing stages in well rested and fatigued subjects. Psychopharmacology 113, 411-421 [DOI] [PubMed] [Google Scholar]
  29. McArdle W.D., Katch F.I., Katch V.L. (2001) Exercise Physiology: Energy, Nutrition and Human Performance. 5thedition Maryland: Lippincott Williams and Wilkins [Google Scholar]
  30. Plaskett C.J., Cafarelli E. (2001) Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions. Journal of Applied Physiology 91, 1535-1544 [DOI] [PubMed] [Google Scholar]
  31. Porkka-Heiskanen T. (1999) Adenosine in sleep and wakefulness. Annals of Medicine 331, 125-129 [DOI] [PubMed] [Google Scholar]
  32. Schneiker K.T., Bishop D., Dawson B., Hackett L.P. (2006) Effects of caffeine on prolonged intermittent sprint ability in team-sport athletes. Medicine and Science in Sports and Exercise 38(3), 578-585 [DOI] [PubMed] [Google Scholar]
  33. Stuart G.R., Hopkins W.G., Cook C., Cairns S.P. (2005) Multiple effects of caffeine on stimulated high-intensity team-sport performance. Medicine and Science in Sports and Exercise 37(11), 1998-2005 [DOI] [PubMed] [Google Scholar]
  34. World Anti-Doping Agency (2008) The world anti-doping code. The 2009 prohibited list. International standard. Retrieved October 24, 2008, from URL: http://www.wada-ama.org/rtecontent/document/2009_Prohibited_List_ENG_Final_20_Sept_08.pdf

Articles from Journal of Sports Science & Medicine are provided here courtesy of Dept. of Sports Medicine, Medical Faculty of Uludag University

RESOURCES